title: Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.
abstract: BACKGROUND
  Parkinson's disease (PD) is a movement neurodegenerative disorder characterized by death of dopaminergic neurons in the substantia nigra pars compacta of the brain that leads to movement impairments including bradykinesia, resting tremor, postural instability and rigidity. Mutations in several genes have been associated with familial PD, such as parkin, pink, DJ-1, LRKK2 and α-synuclein. Lately, mutations in the GBA gene were recognized as a major cause for the development of PD.Mutations in the GBA gene, which encodes for lysosomal β-glucocerebrosidase (GCase), lead to Gaucher disease (GD), an autosomal recessive sphingolipidosis characterized by accumulation of glucosylceramide, mainly in monocyte-derived cells. It is a heterogeneous disease, with Type 1 patients that do not present any primary neurological signs, and Type 2 or Type 3 patients who suffer from a neurological disease. The propensity of type 1 GD patients and carriers of GD mutations to develop PD is significantly higher than that of the non-GD population.We have shown in the past that parkin and mutant GCase, expressed in heterologous systems, interact with each other, and that normal but not mutant parkin mediates K48-dependent proteasomal degradation of mutant GCase variants.
  
  
  METHODS
  We tested possible competition between mutant GCase and PARIS or ARTS on the E3 ubiquitin ligase parkin, using coimmunoprecipitation assays and quantitative real-time PCR.
  
  
  RESULTS
  We show that endogenous mutant GCase variants associate with parkin and undergo parkin-dependent degradation. Mutant GCase competes with the known parkin substrates PARIS and ARTS, whose accumulation leads to apoptosis. Dopaminergic cells expressing mutant GCase are more susceptible to apoptotic stimuli than dopaminergic cells expressing normal GCase, present increased cleavage of caspase 3 and caspase 9 levels and undergo cell death.
  
  
  CONCLUSIONS
  Our results imply that presence of mutant GCase leads to accumulation of parkin substrates like PARIS and ARTS, which may cause apoptotic death of cells.
authors.forename: Inna
authors.initials: I
authors.lastname: Bendikov-Bar
authors.forename: Debora
authors.initials: D
authors.lastname: Rapaport
authors.forename: Sarit
authors.initials: S
authors.lastname: Larisch
authors.affiliation: Department of Cell Research and Immunology, Life Sciences, Tel Aviv University, Levanon St, Ramat Aviv 69978, Israel. horwitzm@post.tau.ac.il.
authors.forename: Mia
authors.initials: M
authors.lastname: Horowitz
mesh_terms: D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D017931:DNA Primers; D005260:Female; D005962:Glucosylceramidase / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008297:Male; D009154:Mutation; D060888:Real-Time Polymerase Chain Reaction; D012097:Repressor Proteins / Q000378:metabolism*; D058112:Septins / Q000378:metabolism*; D013379:Substrate Specificity; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D054875:Ubiquitination
chemical_list: D017931:DNA Primers; D012097:Repressor Proteins; C000591313:ZNF746 protein, human; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D005962:Glucosylceramidase; D020169:Caspases; C492027:SEPTIN4 protein, human; D058112:Septins